Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours.
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 54 (1) , 39-47
- https://doi.org/10.1023/a:1012510513780
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients.1998
- Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind StudyNeurosurgery, 1997
- Mitoxantrone-induced DNA strand breaks in cell-cultures of malignant human astrocytoma and glioblastoma tumors.Journal of Neuro-Oncology, 1997
- Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study)Radiotherapy and Oncology, 1993
- Brachytherapy for Malignant Recurrent and Untreated GliomasStereotactic and Functional Neurosurgery, 1992
- Surgery for glioma relapse factors that influence a favorable outcomeCancer, 1988
- Drug “Diffusion” within the BrainaAnnals of the New York Academy of Sciences, 1988
- Human central nervous system and plasma pharmacology of mitoxantroneJournal of Neuro-Oncology, 1988
- Development of mitoxantroneInvestigational New Drugs, 1985
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980